+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Cervical Dystonia Drug"

From
Cervical Dystonia - Epidemiology Forecast - 2034 - Product Thumbnail Image

Cervical Dystonia - Epidemiology Forecast - 2034

  • Report
  • December 2024
  • 75 Pages
  • Global
From
Cervical Dystonia Market Report and Forecast 2024-2032 - Product Thumbnail Image

Cervical Dystonia Market Report and Forecast 2024-2032

  • Report
  • April 2024
  • 160 Pages
  • Global
From
From
From
Cervical Dystonia - Pipeline Insight, 2024 - Product Thumbnail Image

Cervical Dystonia - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
  • 7 Results (Page 1 of 1)
Loading Indicator

Cervical Dystonia Drug is a type of drug used to treat a neurological disorder characterized by involuntary muscle contractions in the neck and shoulder area. It is a form of Central Nervous System (CNS) drug, which is used to treat a variety of neurological conditions. Cervical Dystonia Drug works by blocking the release of certain neurotransmitters in the brain, which helps to reduce the muscle contractions. Common side effects of these drugs include dry mouth, blurred vision, and drowsiness. The Cervical Dystonia Drug market is a rapidly growing segment of the CNS drug market. It is driven by the increasing prevalence of the disorder, as well as the development of new and improved treatments. The market is expected to continue to grow in the coming years, as more effective treatments become available. Some of the major companies in the Cervical Dystonia Drug market include Allergan, Merz Pharmaceuticals, Teva Pharmaceuticals, and AbbVie. These companies are actively developing new treatments for the disorder, as well as providing existing treatments to patients. Show Less Read more